Novo Holdings to buy Altasciences from Audax Private Equity

Novo Holdings has agreed to acquire Altasciences, a Laval, Quebec-based drug development services provider to pharmaceutical and biotechnology companies.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this